Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
2011 Standout
Biology of Natural Killer Cells
1989 Standout
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
2002 Standout
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
2001 Standout
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
1994 StandoutNature
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
1993
Polymyositis and dermatomyositis
2003 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
In Vitro Approaches to the Mechanism of Cell-Mediated Immune Reactions
1971
Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens.
1977 StandoutNobel
Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex
1975 StandoutNatureNobel
Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells
1977 StandoutNobel
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
2016 Standout
Polymyositis and Dermatomyositis
1975 Standout
Inflammatory Muscle Diseases
2015 Standout
„Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
1975 Standout
Reactivity of lymphocytes from normal persons on cultured tumor cells.
1973
Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour‐specific antigens associated with aminoazo‐dye‐induced rat hepatomas
1971
Cell specificity and an effect of ras on human metallothionein gene expression.
1986
Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.
1979 StandoutNobel
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
In Vitro Detection of Cytotoxic Cellular Immunity Against Tumor-Specific Antigens by a Radioisotopic Technique
1971
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.
1976 StandoutNobel
Demonstration of cell‐mediated immunity to human neoplasms of various histological types
1971
Cellular and humoral immunity against human malignant melanoma
1971
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells
1975 Standout
Cytotoxic lymphocytes in melanoma patients
1972
Hodgkin's Disease: Evidence for a Tumor-Associated Antigen
1971
THE MAMMALIAN URINARY BLADDERAN ACCOMMODATING ORGAN
1975
Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer
1980
Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytes
1972
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
2000 Standout
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.
1978 StandoutNobel
Cellular and humoral immunity to rat hepatoma‐specific antigens correlated with tumour status
1973
Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor Immunity
1974 Standout
Prolonged Bladder Distension as a Treatment of Urgency and Urge Incontinence of Urine
1974
Keyhole-Limpet Haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma
1983
Polymyositis and Dermatomyositis
1975 Standout
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
1982 Standout
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
1987 Standout
Specific killing of tumor cells In vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens
1972
The cancer connection
2002 StandoutNatureNobel
H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.
1975 StandoutNobel
Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products
1977 StandoutNobel
Studies on cellular immunity to human neuroblastoma cells
1970
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.
1975 StandoutNobel
Cell-Mediated Immunity to Tumor Cells
1974
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
1998 StandoutScience
Human natural cell-mediated cytotoxicity
1981
GENETIC CONTROL OF THYMUS-DERIVED CELL FUNCTION
1972 StandoutNobel
Bladder Distension in the Management of Detrusor Instability
1985
Cell‐mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in Murine sarcoma virus (MSV)‐induced tumors and transplanted lymphomas
1972
Detection of Antinuclear Antibodies by Use of an Enzyme Immunoassay with Nuclear HEp-2 Cell Extract and Recombinant Antigens: Comparison with Immunofluorescence Assay in 307 Patients
2001 StandoutNobel
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
1976 Standout
Simple method for measurement of lower extremity muscle strength
1985 Standout
THE PRODUCTION OF MIGRATION INHIBITION FACTOR BY B AND T CELLS OF THE GUINEA PIG
1973 StandoutNobel
T‐Cell‐Mediated Immunopathology in Viral Infections
1974 StandoutNobel
The novel metallothionein genes of Caenorhabditis elegans. Structural organization and inducible, cell-specific expression.
1993 StandoutNobel
Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
1978 StandoutNobel
Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
1997
A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS
1975 StandoutNobel
Purification of Hodgkin's Disease Tumor-Associated Antigens
1973 StandoutNobel
Effect of neuraminidase on electrophoretic mobility and immune cytolysis of human uterine cervix carcinoma cells
1970
T-lymphocyte mediated cytolysis: Temperature dependence of killer cell dependent and independent phases and lack of recovery from the lethal hit at low temperatures
1975 StandoutNobel
Induction of the TRPM-2 gene in cells undergoing programmed death.
1989 Standout
Specificity of Virus‐Immune Effector T Cells for H‐2K or H‐2D Compatible Interactions: Implications for H‐Antigen Diversity
1976 StandoutNobel
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.
1978 StandoutNobel
Characteristics of the Interaction in Vitro Between Cytotoxic Thymus‐Derived Lymphocytes and Target Monolayers Infected with Lymphocytic Choriomeningitis Virus
1974 StandoutNobel
Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
1975 StandoutNobel
Works of K Helmstein being referenced
Cellular and humoral immune responses to human urinary bladder carcinomas
1970
Immune response to urinary bladder tumours in man
1970
TREATMENT OF BLADDER CARCINOMA BY A HYDROSTATIC PRESSURE TECHNIQUE Report on 43 Cases
1972